GEN Exclusives

More »
New Products

Related to Spiral Countercurrent Chromatography

    • LC/MS Data Visualization Software
    • Thermo Fisher Scientific
    • FreeStyle™ 1.0 is a data visualization software for information rendering, method development, and data-quality assessment. It also provides report-writing capabilities. FreeStyle 1.0 is designed to be compatible with both low- and high-resolution
    • Chromatographic Photo Diode Array Detector
    • PerkinElmer
    • The PDA Plus™, a member of the Flexar™ liquid chromatography product family, is a detector that delivers two- and three-dimensional chromatographic information. The detector offers high sampling speeds, a good detection range, high data acquisition
    • Drug Screening Software
    • AB Sciex
    • MPX™ TF 1.0 software is designed to accelerate drug screening on the basis of accurate mass technology. With this software, throughput may be increased by as much as twofold by enabling the use of two parallel liquid chromatography streams. The abi
    • Multiple Peptide Synthesizer
    • Peptide Machines
    • The Discovery-4 automated peptide synthesizer is capable of preparing four peptides at the same time. It can produce peptides from 0.05 to 3.0 mmoles per reactor, and each reactor can run independently following a different scale and protocol. Each
    • Prepacked Chromatography Columns
    • EMD Millipore
    • Chromabolt™ columns are designed for pilot-stage and early-clinical-stage manufacturing. They are offered in three sizes—internal diameters are 10, 20, and 32 cm—and they are available with Fractogel® SO3, Fractogel TMAE HiCap, and Eshmuno
  • Page 1 of 1 (5 items) 1 

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?